The Cooper Companies, Inc. Expected to Post FY2024 Earnings of $3.55 Per Share (NASDAQ:COO)

The Cooper Companies, Inc. (NASDAQ:COO) – Stock analysts at Zacks Research raised their FY2024 earnings per share (EPS) estimates for shares of Cooper Companies in a note issued to investors on Wednesday, June 19th. Zacks Research analyst I. Bandyopadhyay now forecasts that the medical device company will post earnings per share of $3.55 for the year, up from their prior forecast of $3.51. The consensus estimate for Cooper Companies’ current full-year earnings is $3.57 per share. Zacks Research also issued estimates for Cooper Companies’ Q4 2024 earnings at $0.95 EPS, Q1 2025 earnings at $0.90 EPS, Q2 2025 earnings at $0.94 EPS, Q3 2025 earnings at $1.01 EPS, Q4 2025 earnings at $1.04 EPS, FY2025 earnings at $3.89 EPS, Q1 2026 earnings at $0.99 EPS, Q2 2026 earnings at $1.03 EPS and FY2026 earnings at $4.26 EPS.

Several other research firms have also weighed in on COO. Redburn Atlantic upgraded shares of Cooper Companies from a “neutral” rating to a “buy” rating and set a $125.00 price objective on the stock in a research note on Tuesday, March 19th. Mizuho increased their price target on Cooper Companies from $102.50 to $115.00 and gave the stock a “buy” rating in a research report on Friday, March 1st. Robert W. Baird boosted their price objective on Cooper Companies from $116.00 to $118.00 and gave the company an “outperform” rating in a research report on Friday, May 31st. Piper Sandler upped their price target on shares of Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a research report on Friday, March 1st. Finally, TheStreet downgraded Cooper Companies from a “b-” rating to a “c” rating in a research report on Thursday, February 29th. Four research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $111.42.

Cooper Companies Trading Down 0.2 %

Cooper Companies stock opened at $91.51 on Friday. Cooper Companies has a 1 year low of $75.93 and a 1 year high of $104.07. The firm’s 50-day moving average is $92.99 and its 200-day moving average is $94.56. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.14 and a current ratio of 1.95. The company has a market cap of $18.22 billion, a P/E ratio of 53.75, a PEG ratio of 2.27 and a beta of 1.02.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, May 30th. The medical device company reported $0.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.83 by $0.02. Cooper Companies had a return on equity of 8.87% and a net margin of 9.11%. The firm had revenue of $942.60 million for the quarter, compared to analysts’ expectations of $948.07 million. During the same period last year, the business posted $0.77 earnings per share. The firm’s revenue for the quarter was up 7.4% on a year-over-year basis.

Hedge Funds Weigh In On Cooper Companies

A number of institutional investors and hedge funds have recently added to or reduced their stakes in COO. American Trust raised its stake in shares of Cooper Companies by 282.0% in the 1st quarter. American Trust now owns 2,590 shares of the medical device company’s stock worth $263,000 after buying an additional 1,912 shares in the last quarter. EverSource Wealth Advisors LLC grew its holdings in Cooper Companies by 337.6% during the first quarter. EverSource Wealth Advisors LLC now owns 5,347 shares of the medical device company’s stock worth $543,000 after acquiring an additional 4,125 shares during the period. Westwood Holdings Group Inc. raised its position in Cooper Companies by 477.3% in the first quarter. Westwood Holdings Group Inc. now owns 184,012 shares of the medical device company’s stock worth $18,670,000 after acquiring an additional 152,137 shares in the last quarter. DekaBank Deutsche Girozentrale lifted its holdings in Cooper Companies by 100.2% in the 1st quarter. DekaBank Deutsche Girozentrale now owns 37,788 shares of the medical device company’s stock valued at $3,829,000 after acquiring an additional 18,917 shares during the last quarter. Finally, Teachers Retirement System of The State of Kentucky boosted its position in shares of Cooper Companies by 309.5% during the 1st quarter. Teachers Retirement System of The State of Kentucky now owns 17,394 shares of the medical device company’s stock valued at $1,765,000 after purchasing an additional 13,146 shares in the last quarter. 24.39% of the stock is owned by institutional investors.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.